Many team members at Unicorn Nest are Ukrainians affected by Russian aggression. We do our best to solve any issues and answer your questions in the shortest possible time frames but some delays are possible.

BlueYard Capital

Founders Ciaru00e1n O'Leary Jason Whitmire

Overview

Investments

Unlock datapoints

Portfolio analytics

Team

News & Media

Add fund to favorites
info
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.

Need help with fundraising?

We offer an assisted fundraising option for startups

Learn more
Total investments 80
Average round size
info
The average size of a deal this fund participated in
$9M
Portfolio companies 54
Rounds per year 10.00
Lead investments 11
Follow on index
info
How often the fund supports its portfolio startups at next rounds
0.33
Key employees 3
Stages of investment
Early Stage Venture

Areas of investment

  • Software
  • Internet
  • Biotechnology
  • Information Technology
  • Cryptocurrency
Summary

BlueYard Capital appeared to be the VC, which was created in 2016.

The real fund results show that this VC is 48 percentage points more often commits exit comparing to other companies. The important activity for fund was in 2018. The fund is constantly included in 2-6 deals per year. The common things for fund are deals in the range of 5 - 10 millions dollars.

The current fund was established by Ciaru00e1n O'Leary, Jason Whitmire. The overall number of key employees were 3.

Among the various public portfolio startups of the fund, we may underline Filecoin, Pitch, VECTARY Moreover, a startup needs to be at the age of 2-3 years to get the investment from the fund. The fund has no specific favorite in a number of founders of portfolio startups. If startup sums 4 of the founder, the chance for it to be financed is low. We can highlight the next thriving fund investment areas, such as Information Technology, FinTech.

The standard case for the fund is to invest in rounds with 3-4 partakers. Despite the BlueYard Capital, startups are often financed by Union Square Ventures, Andreessen Horowitz, Y Combinator. The meaningful sponsors for the fund in investment in the same round are Union Square Ventures, Andreessen Horowitz, Fabric Ventures. In the next rounds fund is usually obtained by Digital Currency Group, Coinbase Ventures, zk Capital.

Read more

Funds with similar focus

Funds from Germany
Funds with similar focus located in Germany:
Funds with the same geo focus
Funds with similar geography of portfolio companies:
Funds doing lead investments
Funds with similar focus acting as lead investors:

Notable deals

CompanyIndustryRound SizeDateInvestorsLocation

Clock Bio

Biotechnology
Medical
09 Oct 2024 Cambridge, Cambridgeshire, United Kingdom

ExpressionEdits

Biotechnology
Genetics
$13M29 May 2024 Suffolk, England, United Kingdom

Origin.Bio

Biotechnology
Manufacturing
$20M08 May 2024 Germany, Bavaria, Germany

Agnostic

Analytics
Blockchain
Database
Software
$2M04 Mar 2024 Paris, Ile-de-France, France

Zafrens

Biotechnology
Chemical Engineering
Life Science
$23M11 Dec 2023 San Diego, California, United States

Privy

Cyber Security
Developer APIs
$18M21 Nov 2023 -

Ingonyama

Blockchain
Internet
Internet of Things
$21M09 Nov 2023 Petah Tiqva, HaMerkaz, Israel

AnySignal

$5M16 Oct 2023 -

Castelion

Aerospace
Government
Manufacturing
Military
National Security
$14M05 Oct 2023 Washington, District of Columbia, United States
News
Meatable Raises $47 Million Series A to Continue Scaling Trajectory and Expand its Product Portfolio with Beef

– Meatable has closed $47m in Series A funding.
– Consortium consists of Dr. Rick Klausner, Section 32, Dr. Jeffrey Leiden, and DSM Venturing.
– Existing investors, such as BlueYard Capital, Agronomics, Humboldt, and Taavet Hinrikus, show continued support.
– Meatable sees great potential in its technology and is betting on the company to solve the industry’s scalability and speed-to-market challenges with its patented opti-ox™ technology.
– Meatable aims to produce cultivated meat for which no animals are slaughtered, fewer GHG emissions are released, and less land and water are required.

Review

  • No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Coinvestors
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent BlueYard Capital?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!
Total investments 80
Average round size 9M
Rounds per year 10.00
Peak activity year 2023
Lead investments 11
Follow on index 0.33
Group Appearance index 0.85

Latest deals

CompanyIndustryRound SizeDateInvestorsLocation

Clock Bio

Biotechnology
Medical
09 Oct 2024 Cambridge, Cambridgeshire, United Kingdom

ExpressionEdits

Biotechnology
Genetics
$13M29 May 2024 Suffolk, England, United Kingdom

Origin.Bio

Biotechnology
Manufacturing
$20M08 May 2024 Germany, Bavaria, Germany

Agnostic

Analytics
Blockchain
Database
Software
$2M04 Mar 2024 Paris, Ile-de-France, France

Zafrens

Biotechnology
Chemical Engineering
Life Science
$23M11 Dec 2023 San Diego, California, United States

Privy

Cyber Security
Developer APIs
$18M21 Nov 2023 -

Ingonyama

Blockchain
Internet
Internet of Things
$21M09 Nov 2023 Petah Tiqva, HaMerkaz, Israel

AnySignal

$5M16 Oct 2023 -

Castelion

Aerospace
Government
Manufacturing
Military
National Security
$14M05 Oct 2023 Washington, District of Columbia, United States
Crunchbase icon

Content report

The following text will be sent to our editors: